122 related articles for article (PubMed ID: 30361508)
1. Increased invasive phenotype of CSF-1R expression in glioma cells via the ERK1/2 signaling pathway.
Sun L; Liang H; Yu W; Jin X
Cancer Gene Ther; 2019 May; 26(5-6):136-144. PubMed ID: 30361508
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2.
Digiacomo G; Ziche M; Dello Sbarba P; Donnini S; Rovida E
FASEB J; 2015 Jun; 29(6):2545-54. PubMed ID: 25757564
[TBL] [Abstract][Full Text] [Related]
3. The colony-stimulating factor-1 (CSF-1) receptor sustains ERK1/2 activation and proliferation in breast cancer cell lines.
Morandi A; Barbetti V; Riverso M; Dello Sbarba P; Rovida E
PLoS One; 2011; 6(11):e27450. PubMed ID: 22096574
[TBL] [Abstract][Full Text] [Related]
4. GBP3 promotes glioma cell proliferation via SQSTM1/p62-ERK1/2 axis.
Xu H; Sun L; Zheng Y; Yu S; Ou-Yang J; Han H; Dai X; Yu X; Li M; Lan Q
Biochem Biophys Res Commun; 2018 Jan; 495(1):446-453. PubMed ID: 29128363
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of PEBP4 inhibits human glioma cell growth and invasive potential via ERK1/2 signaling pathway.
Huang RQ; Wang SQ; Zhu QB; Guo SC; Shi DL; Chen F; Fang YC; Chen R; Lu YC
Mol Carcinog; 2019 Jan; 58(1):135-143. PubMed ID: 30255656
[TBL] [Abstract][Full Text] [Related]
6. Glial cell-derived neurotrophic factor (GDNF) promotes low-grade Hs683 glioma cell migration through JNK, ERK-1/2 and p38 MAPK signaling pathways.
Song H; Moon A
Neurosci Res; 2006 Sep; 56(1):29-38. PubMed ID: 16814421
[TBL] [Abstract][Full Text] [Related]
7. RTVP-1 promotes mesenchymal transformation of glioma via a STAT-3/IL-6-dependent positive feedback loop.
Giladi ND; Ziv-Av A; Lee HK; Finniss S; Cazacu S; Xiang C; Waldman Ben-Asher H; deCarvalho A; Mikkelsen T; Poisson L; Brodie C
Oncotarget; 2015 Sep; 6(26):22680-97. PubMed ID: 26267319
[TBL] [Abstract][Full Text] [Related]
8. Curcumin inhibits adverse psychological stress-induced proliferation and invasion of glioma cells via down-regulating the ERK/MAPK pathway.
Wang P; Hao X; Li X; Yan Y; Tian W; Xiao L; Wang Z; Dong J
J Cell Mol Med; 2021 Aug; 25(15):7190-7203. PubMed ID: 34169637
[TBL] [Abstract][Full Text] [Related]
9. NKAP alters tumor immune microenvironment and promotes glioma growth via Notch1 signaling.
Gu G; Gao T; Zhang L; Chen X; Pang Q; Wang Y; Wang D; Li J; Liu Q
J Exp Clin Cancer Res; 2019 Jul; 38(1):291. PubMed ID: 31277684
[TBL] [Abstract][Full Text] [Related]
10. CSF-1 receptor signalling from endosomes mediates the sustained activation of Erk1/2 and Akt in macrophages.
Huynh J; Kwa MQ; Cook AD; Hamilton JA; Scholz GM
Cell Signal; 2012 Sep; 24(9):1753-61. PubMed ID: 22575736
[TBL] [Abstract][Full Text] [Related]
11. MAGI3 negatively regulates Wnt/β-catenin signaling and suppresses malignant phenotypes of glioma cells.
Ma Q; Yang Y; Feng D; Zheng S; Meng R; Fa P; Zhao C; Liu H; Song R; Tao T; Yang L; Dai J; Wang S; Jiang WG; He J
Oncotarget; 2015 Nov; 6(34):35851-65. PubMed ID: 26452219
[TBL] [Abstract][Full Text] [Related]
12. SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial-mesenchymal transition and invasion in mice and humans.
Zhang L; Zhang W; Li Y; Alvarez A; Li Z; Wang Y; Song L; Lv D; Nakano I; Hu B; Cheng SY; Feng H
Oncogene; 2016 Oct; 35(43):5641-5652. PubMed ID: 27041571
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-499a decelerates glioma cell proliferation while accelerating apoptosis through the suppression of Notch1 and the MAPK signaling pathway.
Wang BQ; Yang B; Yang HC; Wang JY; Hu S; Gao YS; Bu XY
Brain Res Bull; 2018 Sep; 142():96-106. PubMed ID: 29908894
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of Angiopoietin-Like Protein 2 Inhibits Proliferation and Invasion in Glioma Cells via Suppressing the ERK/MAPK Signaling Pathway.
Yang LK; Zhu J; Chen YH; Wang DL; Li H; Zhang LJ; Zhou JR; Liu W
Oncol Res; 2017 Sep; 25(8):1349-1355. PubMed ID: 28247845
[TBL] [Abstract][Full Text] [Related]
15. Temozolomide inhibits cellular growth and motility via targeting ERK signaling in glioma C6 cells.
Wang Y; Gao S; Wang W; Liang J
Mol Med Rep; 2016 Dec; 14(6):5732-5738. PubMed ID: 27878252
[TBL] [Abstract][Full Text] [Related]
16. Activation of KRas-ERK1/2 signaling drives the initiation and progression of glioma by suppressing the acetylation of histone H4 at lysine 16.
Wei Y; Wang F; Sang B; Xu Z; Yang D
Life Sci; 2019 May; 225():55-63. PubMed ID: 30946839
[TBL] [Abstract][Full Text] [Related]
17. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.
Li S; Zeng A; Hu Q; Yan W; Liu Y; You Y
Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108
[TBL] [Abstract][Full Text] [Related]
18. MiR-148a increases glioma cell migration and invasion by downregulating GADD45A in human gliomas with IDH1 R132H mutations.
Cui D; Sajan P; Shi J; Shen Y; Wang K; Deng X; Zhou L; Hu P; Gao L
Oncotarget; 2017 Apr; 8(15):25345-25361. PubMed ID: 28445981
[TBL] [Abstract][Full Text] [Related]
19. T11TS inhibits Angiopoietin-1/Tie-2 signaling, EGFR activation and Raf/MEK/ERK pathway in brain endothelial cells restraining angiogenesis in glioma model.
Bhattacharya D; Chaudhuri S; Singh MK; Chaudhuri S
Exp Mol Pathol; 2015 Jun; 98(3):455-66. PubMed ID: 25797371
[TBL] [Abstract][Full Text] [Related]
20. Microglial-stimulation of glioma invasion involves the EGFR ligand amphiregulin.
Coniglio SJ; Segall JE
PLoS One; 2021; 16(11):e0260252. PubMed ID: 34843542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
